Mapping the HBsAg immune phenotype to predict HBsAg decline in chronic hepatitis B in patients receiving nucleot(s)ide analogue therapy

被引：0
|
作者：
Lim, L. Y. [1 ,2 ]
Yuen, L. [1 ]
Hammond, R. [1 ,2 ]
Angus, P. W.
Thompson, A. J. [1 ,2 ,3 ]
Patterson, S. J.
Leary, T. [4 ]
Yi, P. [4 ]
Thomas, H. [5 ]
Locarnini, S. [1 ]
Walsh, R. [1 ]
机构：
[1] Victorian Infect Dis Reference Lab, Div Mol Res & Dev, North Melbourne, Vic 3051, Australia
[2] Austin Hosp, Dept Gastroenterol, Heidelberg, Vic 3084, Australia
[3] St Vincents Hosp, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[4] Abbott Labs, Chicago, IL 60064 USA
[5] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [41] Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?
    Siederdissen, C. Hoener Zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R.
    Cornberg, M.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 50 - 50
  • [42] Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus
    Ana?s Brayette
    Marie Essig
    Paul Carrier
    Marilyne Debette-Gratien
    Ana?s Labrunie
    Sophie Alain
    Marianne Maynard
    Nathalie Ganne-Carrié
    Eric Nguyen-Khac
    Pauline Pinet
    Victor De Ledinghen
    Christophe Renou
    Philippe Mathurin
    Claire Vanlemmens
    Vincent Di Martino
    Anne Gervais
    Juliette Foucher
    Fouchard-Hubert Isabelle
    Julien Vergniol
    Isabelle Hourmand-Ollivier
    Daniel Cohen
    Xavier Duval
    Thierry Poynard
    Marc Bardou
    Armand Abergel
    Manh-Thong Dao
    Thierry Thévenot
    Jérémie Jacques
    Véronique Loustaud-Ratti
    Guillaume Lassailly
    Christine Aurières
    Nathalie Boyer
    Dominique Thabut
    Pierre-Henri Bernard
    Matthieu Schnee
    Dominique Larrey
    Bertrand Hanslik
    Séverine Hommel
    Jean-Baptiste Hiriart
    Valérie Canva
    World Journal of Hepatology, 2020, 12 (12) : 1326 - 1340
  • [43] A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interimanalysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare
    Hall, Samuel
    Burns, Gareth
    Levy, Miriam
    Lubel, John
    Nicoll, Amanda
    Matthews, Gail
    Desmond, Paul
    Sievert, William
    Bowden, Scott
    Locarnini, Stephen
    Holmes, Jacinta
    JOURNAL OF HEPATOLOGY, 2020, 73 : S69 - S70
  • [44] Risk of Hepatocellular Carcinoma after HBsAg Seroclearance Associated with Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B
    Kim, Gi Ae
    Han, Seungbong
    An, Jihyun
    Suh, Dong Jin
    Lim, Young-Suk
    HEPATOLOGY, 2013, 58 : 629A - 630A
  • [45] Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy
    Zhang, Li
    Zhang, Miao
    Li, Hu
    Chen, Zhiwei
    Luo, Aoran
    Liu, Bin
    Chen, Min
    Peng, Mingli
    Ren, Hong
    Hu, Peng
    MOLECULAR IMMUNOLOGY, 2016, 73 : 37 - 45
  • [46] WEEK 12 HBSAG TITER DECLINE IS PREDICTIVE OF SVR IN CHRONIC HEPATITIS B PATIENTS RECEIVING PEGYLATED INTERFERON PLUS TENOFOVIR COMBINATION THERAPY
    Marcellin, P.
    Martinot-Peignoux, M.
    Lapalus, M.
    Lada, O.
    Zhang, Q.
    Boyer, N.
    Asselah, T.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S209 - S210
  • [47] Association between core mutations and annual decline rate of HBVDNA and HBsAg in chronic hepatitis B patients treated with nucleoside analogue
    Honda, Takashi
    Ishigami, Masatoshi
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Fujishiro, Mitsuhiro
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E258 - E258
  • [48] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBsAg LEVELS IN HBeAg-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE TREATMENT: THE HERMES STUDY
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Palmieri, G.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S276 - S276
  • [49] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [50] Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy
    Matsuda, Shuya
    Maekawa, Shinya
    Komiyama, Yasuyuki
    Nakakuki, Natsuko
    Muraoka, Masaru
    Suzuki, Yuichiro
    Sato, Mitsuaki
    Tatsumi, Akihisa
    Miura, Mika
    Amemiya, Fumitake
    Shindo, Hiroko
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Yamaguchi, Tatsuya
    Nakayama, Yasuhiro
    Inoue, Taisuke
    Sato, Tadashi
    Yamashita, Atsuya
    Moriishi, Kohji
    Enomoto, Nobuyuki
    HEPATOLOGY RESEARCH, 2021, 51 (01) : 39 - 50
12345